Follistatin

Myostatin normally binds activin type 2 receptors and activates SMAD signaling that restrains skeletal muscle growth.

Folistatin can bind myostatin before receptor activation, but conventional folistatin also binds activins.

FLGR 242 is advertised as a modified folistatin construct that retains myostatin antagonism, largely avoids activin, and binds albumin to remain in circulation longer.

If all three features are confirmed, it would be a more targeted tool.

It is not medical advice, a dosing guide, or a recommendation to use an experimental product.

Follistatin is not an FDA-approved muscle building medication.

Today's listener question is very simple: If myostatin limits muscle growth, can follistatin remove that limit? Biologically, yes, at least in part.

Clinically, the answer becomes much more complicated.

Training, nutrition, recovery, hormones, and genetics press the accelerator.

Myostatin helps prevent uncontrolled acceleration.

Follistatin binds myostatin before it activates that receptor pathway.

Reduce the signal and the muscle growth break becomes weaker.